Home › Quest Diagnostics Inc (DGX) Upgraded at Mizuho
 

Keywords :   


Quest Diagnostics Inc (DGX) Upgraded at Mizuho

2016-03-07 06:33:23| Biotech - Topix.net

The firm presently has a $75.00 target price on the stock, up from their prior target price of $68.00. Mizuho's target price points to a potential upside of 8.19% from the company's previous close.

Tags: quest upgraded diagnostics mizuho

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
15.05Renters in scrum for homes as listing time slashed
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
14.05P&G Unveils Plans to Feature Brands During the Olympic and Paralympic Games Paris 2024
14.05The LOccitane Group Appoints Evelyne LY-Wainer Managing Director Global Travel Retail
More »